Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4628)
All Articles published online
|
Mar 7, 2012 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hua D, Sun J, Mao Y, Chen LJ, Wu YY, Zhang XG. B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma. World J Gastroenterol 2012; 18(9): 971-978 [PMID: 22408358 DOI: 10.3748/wjg.v18.i9.971] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i9/971.htm |
| Number | Citing Articles |
| 1 |
Yilun Wu, Weiyu Chen, Zhi Ping Xu, Wenyi Gu. PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02022
|
| 2 |
Upik A. Miskad, Nursakti Hamzah, Muhammad H. Cangara, Berti J. Nelwan, Rina Masadah, Syarifuddin Wahid. Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in colorectal adenocarcinoma. Minerva Medica 2020; 111(4) doi: 10.23736/S0026-4806.20.06401-0
|
| 3 |
Iman M. Talaat, Noha M. Elemam, Shroque Zaher, Maha Saber-Ayad. Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.955599
|
| 4 |
Jingying Hou, Zhong Yu, Rengyun Xiang, Chuqiang Li, Lin Wang, Shufen Chen, Qingyun Li, Mei Chen, Linyun Wang. Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer. Experimental and Molecular Pathology 2014; 96(3): 284 doi: 10.1016/j.yexmp.2014.03.005
|
| 5 |
Yu Zhou, Jun-quan Liu, Zhong-hai Zhou, Xiao-ting LV, Yong-qiang Chen, Lei-qing Sun, Fu-xing Chen. Enhancement of CD3AK cell proliferation and killing ability by α-Thujone. International Immunopharmacology 2016; 30: 57 doi: 10.1016/j.intimp.2015.11.027
|
| 6 |
Said Dermime, Sehar Afreen. The immunoinhibitory B7-H1 molecule as a potential target in cancer. Hematology/Oncology and Stem Cell Therapy 2014; 7(1): 1 doi: 10.1016/j.hemonc.2013.09.005
|
| 7 |
María Sanchez-Castañón, Tze-Kiong Er, Luis Bujanda, Marta Herreros-Villanueva. Immunotherapy in colorectal cancer: What have we learned so far?. Clinica Chimica Acta 2016; 460: 78 doi: 10.1016/j.cca.2016.06.027
|
| 8 |
Mauro Giacomelli, Matilde Monti, Diego Cesare Pezzola, Silvia Lonardi, Mattia Bugatti, Francesco Missale, Rossella Cioncada, Laura Melocchi, Viviana Giustini, Vincenzo Villanacci, Carla Baronchelli, Stefania Manenti, Luisa Imberti, Emanuele Giurisato, William Vermi. Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma. Cancers 2023; 15(12): 3097 doi: 10.3390/cancers15123097
|
| 9 |
Hao Qiu, Liang Zheng, Weifeng Tang, Pengfei Yin, Feng Cheng, Lixin Wang. Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer. Clinical Biochemistry 2014; 47(7-8): 612 doi: 10.1016/j.clinbiochem.2013.12.023
|
| 10 |
Jung-Soo Pyo, Guhyun Kang, Jung Yeon Kim. Prognostic Role of PD-L1 in Malignant Solid Tumors: A Meta-Analysis. The International Journal of Biological Markers 2017; 32(1): 68 doi: 10.5301/jbm.5000225
|
| 11 |
Junying Xu, Xuejing Yang, Yong Mao, Jie Mei, Huiyu Wang, Junli Ding, Dong Hua. Removal of N-Linked Glycosylation Enhances PD-L1 Detection in Colon Cancer: Validation Research Based on Immunohistochemistry Analysis. Technology in Cancer Research & Treatment 2021; 20 doi: 10.1177/15330338211019442
|
| 12 |
Chao Wu, Jingyue Yang, Rui Ding, Xiao Li, Zhi Yang, Min Zhu, Zhengcai Liu. Identification of a costimulatory molecule-based signature to predict prognostic risk of pancreatic adenocarcinoma. All Life 2022; 15(1): 808 doi: 10.1080/26895293.2022.2090450
|
| 13 |
Anna Pous, Lucía Notario, Cinta Hierro, Laura Layos, Cristina Bugés. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies. International Journal of Molecular Sciences 2023; 24(14): 11403 doi: 10.3390/ijms241411403
|
| 14 |
Lucas Leite Cunha, Marjory Alana Marcello, Elaine Cristina Morari, Suely Nonogaki, Fábio Frangiotti Conte, René Gerhard, Fernando Augusto Soares, José Vassallo, Laura Sterian Ward. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation. Endocrine-Related Cancer 2013; 20(1): 103 doi: 10.1530/ERC-12-0313
|
| 15 |
Jianjie Zhu, Lanxin Chen, Lingting Zou, Panpan Yang, Ruirong Wu, Yong Mao, Huan Zhou, Rui Li, Kaicai Wang, Weipeng Wang, Dong Hua, Xueguang Zhang. MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer. Human Immunology 2014; 75(4): 348 doi: 10.1016/j.humimm.2014.01.006
|
| 16 |
Yan Ge, Wei Chen, Xueguang Zhang, Haiyan Wang, Juanjuan Cui, Yue Liu, Songwen Ju, Xinxin Tian, Songguang Ju. Nuclear-localized costimulatory molecule 4-1BBL promotes colon cancer cell proliferation and migration by regulating nuclear Gsk3β, and is linked to the poor outcomes associated with colon cancer. Cell Cycle 2020; 19(5): 577 doi: 10.1080/15384101.2020.1719308
|
| 17 |
Yong-Hong Huang, Yun-Fei Cao, Zhi-Yuan Jiang, Sen Zhang, Feng Gao. Th22 cell accumulation is associated with colorectal cancer development. World Journal of Gastroenterology 2015; 21(14): 4216-4224 doi: 10.3748/wjg.v21.i14.4216
|
| 18 |
Julie Jacobs, Evelien Smits, Filip Lardon, Patrick Pauwels, Vanessa Deschoolmeester. Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect. Journal of Immunology Research 2015; 2015: 1 doi: 10.1155/2015/158038
|
| 19 |
Barbara Seliger. Basis of PD1/PD-L1 Therapies. Journal of Clinical Medicine 2019; 8(12): 2168 doi: 10.3390/jcm8122168
|
| 20 |
Alexandra Lapeyre-Prost, Magali Terme, Simon Pernot, Elie Marcheteau, Anne-Laure Pointet, Thibault Voron, Eric Tartour, Julien Taieb. Immune therapy in colorectal cancer. Colorectal Cancer 2017; 6(1): 1 doi: 10.2217/crc-2017-0002
|
| 21 |
Pramila Chaubey, Munira Momin, Sujata Sawarkar. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01628
|
| 22 |
Mingshui Chen, Aditi Sharma, Yanling Lin, Yanheng Wu, Qi He, Yushu Gu, Zhi Ping Xu, Michael Monteiro, Wenyi Gu. Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5364-3
|
| 23 |
Yohei Masugi, Reiko Nishihara, Juhong Yang, Kosuke Mima, Annacarolina da Silva, Yan Shi, Kentaro Inamura, Yin Cao, Mingyang Song, Jonathan A Nowak, Xiaoyun Liao, Katsuhiko Nosho, Andrew T Chan, Marios Giannakis, Adam J Bass, F Stephen Hodi, Gordon J Freeman, Scott Rodig, Charles S Fuchs, Zhi Rong Qian, Shuji Ogino. Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut 2017; 66(8): 1463 doi: 10.1136/gutjnl-2016-311421
|
| 24 |
Jae Joon Han, Dong-Wan Kim, Jaemoon Koh, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Doo Hyun Chung, Dae Seog Heo. Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2016; 17(4): 263 doi: 10.1016/j.cllc.2015.11.006
|
| 25 |
|
| 26 |
Honggeng Guan, Yang Lan, Yuqiu Wan, Qin Wang, Cheng Wang, Longjiang Xu, Yongjing Chen, Wenting Liu, Xueguang Zhang, Yecheng Li, Yongping Gu, Zemin Wang, Fang Xie. PD-L1 mediated the differentiation of tumor-infiltrating CD19+B lymphocytes and T cells in Invasive breast cancer. OncoImmunology 2016; 5(2): e1075112 doi: 10.1080/2162402X.2015.1075112
|
| 27 |
Maria A. Smolle, Horatiu N. Calin, Martin Pichler, George A. Calin. Noncoding RNAs and immune checkpoints—clinical implications as cancer therapeutics. The FEBS Journal 2017; 284(13): 1952 doi: 10.1111/febs.14030
|
| 28 |
Xiang Li, Jing Nie, Qian Mei, Wei-Dong Han. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma. World Journal of Gastroenterology 2016; 22(23): 5317-5331 doi: 10.3748/wjg.v22.i23.5317
|
| 29 |
|
| 30 |
Iris N. Pardieck, Priscilla A. Jawahier, Marloes Swets, Cornelis J.H. van de Velde, Peter J.K. Kuppen. Novel avenues in immunotherapies for colorectal cancer. Expert Review of Gastroenterology & Hepatology 2016; 10(4): 465 doi: 10.1586/17474124.2016.1122522
|
| 31 |
Alexandr V. Bazhin, Katharina von Ahn, Caroline Maier, Sabine Soltek, Susanne Serba, Linda Diehl, Jens Werner, Svetlana Karakhanova. Immunological in vivo effects of B7-H1 deficiency. Immunology Letters 2014; 162(2): 273 doi: 10.1016/j.imlet.2014.08.013
|
| 32 |
Zhe Xu Cao, Xin Weng, Jiang Sheng Huang, Xia Long. Receptor–ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.902550
|
| 33 |
Pablo A. González, Leandro J. Carreño, Pablo F. Céspedes, Susan M. Bueno, Claudia A. Riedel, Alexis M. Kalergis. Modulation of Tumor Immunity by Soluble and Membrane-Bound Molecules at the Immunological Synapse. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/450291
|
| 34 |
Lu-Lu Yang, Yi-Long Wu. Recent Advances of Immunotherapy in Lung Cancer: Anti-Programmed Cell Death-1/Programmed Death Ligand-1 Antibodies. Lung Cancer Management 2014; 3(2): 175 doi: 10.2217/lmt.13.80
|
| 35 |
Yidan Zhi, Zhirong Mou, Jun Chen, Yujun He, Hui Dong, Xiaolan Fu, Yuzhang Wu, Giuseppe Pirozzi. B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells. PLOS ONE 2015; 10(8): e0135528 doi: 10.1371/journal.pone.0135528
|
| 36 |
Xinran Chen, Wei Wang, Hongwei Man, Pengfei Li, Baoen Shan. Increased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in mice. Oncology Letters 2017; 13(4): 2207 doi: 10.3892/ol.2017.5688
|